Successful treatment of a bullous vasculitis with intravenous immunoglobulins in a COVID-19 patient

Dermatol Ther. 2021 Mar;34(2):e14853. doi: 10.1111/dth.14853. Epub 2021 Feb 18.

Authors

Elisa Zavattaro^{1

2}, Edoardo Cammarata^{1

3}, Vanessa Tarantino^{1

3}, Daniele Soddu^{1

2}, Laura C Gironi¹, Paola Savoia^{1

3}

Affiliations

¹ Maggiore della Carità University Hospital, Novara, Italy.
² Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
³ Department of Health Science, University of Eastern Piedmont, Novara, Italy.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Humans
Immunoglobulins, Intravenous
SARS-CoV-2
Skin
Vasculitis*

Substances

Immunoglobulins, Intravenous